SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 26.62 EUR 1.53% Market Closed
Market Cap: 4B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCHOTT Pharma AG & Co KgaA
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Other Long-Term Assets
€15.3m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Other Long-Term Assets
€36.1m
CAGR 3-Years
12%
CAGR 5-Years
-1%
CAGR 10-Years
68%
Gerresheimer AG
XETRA:GXI
Other Long-Term Assets
€13.9m
CAGR 3-Years
5%
CAGR 5-Years
-5%
CAGR 10-Years
6%
No Stocks Found

SCHOTT Pharma AG & Co KgaA
Glance View

Market Cap
4B EUR
Industry
Life Sciences Tools & Services

SCHOTT Pharma AG & Co KgaA is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Mainz, Hessen. The company went IPO on 2023-09-28. SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The firm's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.

1SXP Intrinsic Value
34.05 EUR
Undervaluation 22%
Intrinsic Value
Price

See Also

What is SCHOTT Pharma AG & Co KgaA's Other Long-Term Assets?
Other Long-Term Assets
15.3m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Other Long-Term Assets amounts to 15.3m EUR.

What is SCHOTT Pharma AG & Co KgaA's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
17%

Over the last year, the Other Long-Term Assets growth was 26%. The average annual Other Long-Term Assets growth rates for SCHOTT Pharma AG & Co KgaA have been 17% over the past three years .

Back to Top